Economic burden of herpes zoster in Latin America: A systematic review and meta-analysis

References

• Bardach A, Cafferata ML, Klein K, Cormick G, Gibbons L, Ruvinsky S. Incidence and use of resources for chickenpox and herpes zoster in Latin America and the Caribbean—a systematic review and meta-analysis. Pediatr Infect Dis J. 2012;31(12):1263–13. doi:10.1097/INF.0b013e31826ff3a5.
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, Betts RF, Gershon AA, Haanpaa ML, McKendrick MW, et al. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007;44(Suppl 1):S1–26.
   PubMed Web of Science ®Google Scholar
• Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, Grose C, Hambleton S, Kennedy PG, Oxman MN, et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015;1(1):15016. doi:10.1038/nrdp.2015.16.
   PubMedGoogle Scholar
• Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of Varicella–zoster virus. N Engl J Med. 2000;342(9):635–45. doi:10.1056/NEJM200003023420906.
   PubMed Web of Science ®Google Scholar
• Schmutzhard J, Merete Riedel H, Zweygberg Wirgart B, Grillner L. Detection of herpes simplex virus type 1, herpes simplex virus type 2 and varicella-zoster virus in skin lesions. Comparison of real-time PCR, nested PCR and virus isolation. J Clin Virol. 2004;29(2):120–26. doi:10.1016/S1386-6532(03)00113-6.
   PubMed Web of Science ®Google Scholar
• Bennett J, Dolin R, Blaser M. Mandell, Douglas and Bennett's - principles and practice of infectious diseases. Philadelphia (PA): Elsevier; 2019.
   Google Scholar
• Yawn BP, Gilden D. The global epidemiology of herpes zoster. Neurology. 2013;81(10):928–30. doi:10.1212/WNL.0b013e3182a3516e.
   PubMed Web of Science ®Google Scholar
• Cohen JI. Herpes zoster. New Engl J Med. 2013;369(3):255–63. doi:10.1056/NEJMcp1302674.
   PubMed Web of Science ®Google Scholar
• Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82(11):1341–49. doi:10.4065/82.11.1341.
   PubMed Web of Science ®Google Scholar
• Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4(6):e004833. doi:10.1136/bmjopen-2014-004833.
   PubMed Web of Science ®Google Scholar
• Schmader K. Herpes zoster in older adults. Clin Infect Dis. 2001;32(10):1481–86. doi:10.1086/320169.
   PubMed Web of Science ®Google Scholar
• Buchbinder SP, Katz MH, Hessol NA, Liu JY, O’Malley PM, Underwood R, Holmberg SD. Herpes zoster and human immunodeficiency virus infection. J Infect Dis. 1992;166(5):1153–56. doi:10.1093/infdis/166.5.1153.
   PubMed Web of Science ®Google Scholar
• Chen SY, Suaya JA, Li Q, Galindo CM, Misurski D, Burstin S, Levin MJ. Incidence of herpes zoster in patients with altered immune function. Infection. 2014;42(2):325–34. doi:10.1007/s15010-013-0550-8.
   PubMed Web of Science ®Google Scholar
• Grabar S, Tattevin P, Selinger-Leneman H, de La Blanchardiere A, de Truchis P, Rabaud C, Rey D, Daneluzzi V, Ferret S, Lascaux AS, et al. Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort. Clin Infect Dis. 2015;60(8):1269–77. doi:10.1093/cid/ciu1161.
   PubMed Web of Science ®Google Scholar
• Levin MJ, Anderson JP, Seage GR 3rd, Williams PL. Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children. J Acquir Immune Defic Syndr. 2009;50(2):182–91. doi:10.1097/QAI.0b013e31819550a4.
   PubMed Web of Science ®Google Scholar
• Schmader K, George LK, Burchett BM, Pieper CF, Hamilton JD. Racial differences in the occurrence of herpes zoster. J Infect Dis. 1995;171(3):701–04. doi:10.1093/infdis/171.3.701.
   PubMed Web of Science ®Google Scholar
• Watson PN, Evans RJ. Postherpetic neuralgia. A review. Arch Neurol. 1986;43(8):836–40. doi:10.1001/archneur.1986.00520080074027.
   PubMedGoogle Scholar
• Ragozzino MW, Melton LJ 3rd, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982;61(5):310–16. doi:10.1097/00005792-198209000-00003.
   PubMed Web of Science ®Google Scholar
• Elliott KJ. Other neurological complications of herpes zoster and their management. Ann Neurol. 1994;35(S1):S57–61. doi:10.1002/ana.410350717.
   PubMedGoogle Scholar
• Liesegang TJ. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology. 2008;115(2):S3–12. doi:10.1016/j.ophtha.2007.10.009.
   PubMed Web of Science ®Google Scholar
• Mishell JH, Applebaum EL. Ramsay-Hunt syndrome in a patient with HIV infection. Otolaryngol Head Neck Surg. 1990;102(2):177–79. doi:10.1177/019459989010200215.
   PubMed Web of Science ®Google Scholar
• Wood MJ, Kay R, Dworkin RH, Soong SJ, Whitley RJ. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis. 1996;22(2):341–47. doi:10.1093/clinids/22.2.341.
   PubMed Web of Science ®Google Scholar
• Hempenstall K, Nurmikko TJ, Johnson RW, A’Hern RP, Rice AS, Woolf CJ. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med. 2005;2(7):e164. doi:10.1371/journal.pmed.0020164.
   PubMed Web of Science ®Google Scholar
• CDC. Update on herpes zoster vaccine: licensure for persons aged 50 through 59 years. MMWR Morb Mortal Wkly Rep. 2011;60:1528.
   PubMedGoogle Scholar
• Willis ED, Woodward M, Brown E, Popmihajlov Z, Saddier P, Annunziato PW, Halsey NA, Gershon AA. Herpes zoster vaccine live: a 10 year review of post-marketing safety experience. Vaccine. 2017;35(52):7231–39. doi:10.1016/j.vaccine.2017.11.013.
   PubMed Web of Science ®Google Scholar
• Administración Nacional de Medicamentos AyTMA. Disposición ANMAT N° 1850-2013. 2013 [accessed 2021 Mar 12]. http://www.anmat.gov.ar/boletin_anmat/marzo_2013/Dispo_1850-13.pdf.
   Google Scholar
• Food and Drug Administration. May 25, 2006 approval letter - Zostavax. STN 125123/0, approval of biologics license application (BLA) for zoster vaccine, Live, (Oka/Merck). 2006 [accessed 2021 Mar 12]. http://wayback.archive-it.org/7993/20170723093336/https:/www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm132873.htm.
   Google Scholar
• Dooling KL, Guo A, Patel M, Lee GM, Moore K, Belongia EA, Harpaz R. Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines. MMWR Morb Mortal Wkly Rep. 2018;67(3):103–08. doi:10.15585/mmwr.mm6703a5.
   PubMed Web of Science ®Google Scholar
• Anderson TC, Masters NB, Guo A, Shepersky L, Leidner AJ, Lee GM, Kotton CN, Dooling KL. Use of Recombinant Zoster Vaccine in immunocompromised adults aged ≥19 years: recommendations of the advisory committee on immunization practices — United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(3):80–84. doi:10.15585/mmwr.mm7103a2.
   PubMed Web of Science ®Google Scholar
• CDC. Clinical considerations for use of Recombinant Zoster Vaccine (RZV, Shingrix) in immunocompromised adults aged ≥19 years. 2022 [accessed 2022 Jul 27]. https://www.cdc.gov/shingles/vaccination/immunocompromised-adults.html.
   Google Scholar
• The World Bank. The world by income and region. 2022 [accessed 2022 Aug 29]. https://datatopics.worldbank.org/world-development-indicators/the-world-by-income-and-region.html.
   Google Scholar
• Bardach AE, Palermo C, Alconada T, Sandoval M, Balan DJ, Nieto Guevara J, Gómez J, Ciapponi A, Andrei G. Herpes zoster epidemiology in Latin America: a systematic review and meta-analysis. PLoS One. 2021;16(8):e0255877. doi:10.1371/journal.pone.0255877.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane handbook for systematic reviews of interventions version 6.0 (updated August 2019). 2021 [accessed 2021 Mar 12]. https://training.cochrane.org/handbook.
   Google Scholar
• Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, The PG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097.
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. Jama. 2000;283:2008–12.
   PubMed Web of Science ®Google Scholar
• Agustín Ciapponi AB, Comandé D, Zambosco TA, Palermo MC, Balan D, Sandoval MM. Burden of herpes zoster in Latin America: a systematic review and meta-analysis. PROSPERO 2020 CRD42020186586. 2020 [accessed 2021 Mar 12]. https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=186586.
   Google Scholar
• The Institute for Health Metrics and Evaluation (IHME). GBD compare- Viz Hub. 2017 [accessed 2021 Feb 12]. https://vizhub.healthdata.org/gbd-compare/.
   Google Scholar
• Babineau J. Product review: covidence (systematic review software). Journal of the Canadian Health Libraries Association / Journal de l’Association des Bibliothèques de la Santé du Canada. 2014;35(2):68–71. doi:10.5596/c14-016.
   Google Scholar
• Veritas Health Innovation . Covidence systematic review software. Melbourne (Australia). 2021. https://www.covidence.org/.
   Google Scholar
• Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E. Consolidated health economic evaluation reporting standards (Cheers)—explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force. Value Health. 2013;16(2):231–50. doi:10.1016/j.jval.2013.02.002.
   PubMed Web of Science ®Google Scholar
• Mandrik O, Severens JL, Bardach A, Ghabri S, Hamel C, Mathes T, Vale L, Wisløff T, Goldhaber-Fiebert JD. Critical appraisal of systematic reviews with costs and cost-effectiveness outcomes: an ISPOR good practices task force report. Value Health. 2021;24(4):463–72. doi:10.1016/j.jval.2021.01.002.
   PubMed Web of Science ®Google Scholar
• National Institutes of Health. Study quality assessment tools. 2019 [accessed 2021 May 26]. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools.
   Google Scholar
• World Bank. Official exchange rate (LCU per US$, period average). 2020 [accessed 2021 Mar 12]. https://data.worldbank.org/indicator/PA.NUS.FCRF.
   Google Scholar
• World Bank. Inflation, consumer prices (annual %). 2020 [accessed 2021 Mar 12]. https://data.worldbank.org/indicator/FP.CPI.TOTL.ZG.
   Google Scholar
• World Bank. PPP conversion factor, GDP (LCU per international $). 2020 [accessed 2021 Mar 12]. https://data.worldbank.org/indicator/PA.NUS.PPP.
   Google Scholar
• Bollea-Garlatti ML, Bollea-Garlatti LA, Vacas AS, Torre AC, Kowalczuk AM, Galimberti RL, Ferreyro BL. Clinical characteristics and outcomes in a population with disseminated herpes zoster: a retrospective cohort study. Actas Dermo-Sifiliográficas (English Edition). 2017;108(2):145–52. doi:10.1016/j.adengl.2016.12.019.
   Google Scholar
• Corti M, Villafañe MF, Vittar N, Banco MC, Priarone M, Mammana L, Gilardi L. Meningoencephalitis due to varicella zoster virus in aids patients. Report of eleven cases and review of the literature. Revista Do Instituto de Medicina Tropical de São Paulo. 2015;57(6):505–08. doi:10.1590/S0036-46652015000600007.
   PubMed Web of Science ®Google Scholar
• Rampakakis E, Pollock C, Vujacich C, Toniolo Neto J, Ortiz Covarrubias A, Monsanto H, Johnson KD. Economic burden of herpes zoster (“culebrilla”) in Latin America. Int J Infect Dis. 2017;58:22–26.
   PubMed Web of Science ®Google Scholar
• Rozenek M, Romani A, Aronson S, Ramilo MD, Abellán V, Pérez MA, Cámera L. [Herpes zoster in elderly adults in a community hospital in Buenos Aires. June 2013-May 2014]. Medicina (B Aires). 2017;77:24–30.
   PubMed Web of Science ®Google Scholar
• Vujacich C, Poggi E, Cecchini D, Luchetti P, Stamboulian D. Herpes zoster: epidemiología y clínica [Clinical and epidemiological aspects of Herpes zoster]. Medicina (BAires). 2008;68:125–28.
   PubMedGoogle Scholar
• Vujacich C, de Wouters L, Margari AM, Gordóvil M, Rampakakis E, Psaradellis E, Sampalis JS, Johnson K, Montes JL, Monsanto HA, et al. Dolor, calidad de vida relacionada con la salud y utilización de servicios médicos asociados al herpes zoster en Argentina. Actualizaciones En SIDA E Infectología. 2016;24:53–63.
   Google Scholar
• Alvarez FK, de Siqueira SR, Okada M, Teixeira MJ, de Siqueira JT. Evaluation of the sensation in patients with trigeminal post-herpetic neuralgia. J Oral Pathol Med. 2007;36(6):347–50. doi:10.1111/j.1600-0714.2006.00489.x.
   PubMed Web of Science ®Google Scholar
• Andrade FMX, Bezerra FM, Santos MSD, Araujo M. Perfil clínico e achados oftalmológicos no herpes zoster Oftálmico. Rev Bras Oftalmol. 2019;78(3):170–74. doi:10.5935/0034-7280.20190122.
   Google Scholar
• Antoniolli L, Rodrigues C, Borges R, Goldani LZ. Epidemiology and clinical characteristics of herpes zoster in a tertiary care hospital in Brazil. Braz J Infect Dis. 2019;23(2):143–45. doi:10.1016/j.bjid.2019.03.001.
   PubMed Web of Science ®Google Scholar
• Borba EF, Ribeiro AC, Martin P, Costa LP, Guedes LK, Bonfá E. Incidence, risk factors, and outcome of herpes zoster in systemic lupus erythematosus. J Clin Rheumatol. 2010;16(3):119–22. doi:10.1097/RHU.0b013e3181d52ed7.
   PubMed Web of Science ®Google Scholar
• Gormezano NW, Silva CA, Otsuzi CI, Barros DL, da Silva MA, Sallum AM, Pasoto S, Pereira RM, Bonfa E. Higher prevalence and distinct features of herpes zoster infection in children than adults with systemic lupus erythematosus. Pediatr Infect Dis J. 2015;34(8):905–07. doi:10.1097/INF.0000000000000756.
   PubMed Web of Science ®Google Scholar
• Toniolo-Neto J, Psaradellis E, Karellis A, Rampakakis E, Rockett TY, Sampalis JS, Johnson KD, Monsanto HA, Acosta CJ. Measuring herpes zoster disease burden in São Paulo, Brazil: a clinico-epidemiological single-center study. Clinics. 2018;73:e243. doi:10.6061/clinics/2018/e243.
   PubMed Web of Science ®Google Scholar
• Ordoñez Molina JE, Orozco Giraldo JJ, Gutierrez-Ardila MV. Budget impact of pregabalin for the treatment of neuropathic pain in Colombia. Value Health. 2013;16(3):A114. doi:10.1016/j.jval.2013.03.546.
   PubMed Web of Science ®Google Scholar
• Ordoñez Molina JE, Orozco Giraldo JJ, Gutierrez-Ardila MV. Cost-effectiveness analysis of pregabalin for the treatment of neuropathic pain in Colombia. Value Health. 2013;16(3):A118. doi:10.1016/j.jval.2013.03.568.
   Web of Science ®Google Scholar
• Rampakakis E, Monsanto HA, Stutz M, Psaradellis E, Mejia G, Carillo AE, Zapata-Cardenas A, Molina DC, Molina de Salazar DI, Pradilla Vesga OE, et al. Burden of illness of herpes zoster in Colombia: an observational study. Value Health Reg Issues. 2019;19:S43.
   Google Scholar
• Rampakakis E, Alpizar C, Karellis A, Sampalis JS, Johnson K, Monsanto HA, Acosta CJ. Measuring the burden of herpes zoster disease in Costa Rica. Acta Méd Costarric. 2017;59:146–52.
   Google Scholar
• Ortiz-Covarrubias A. Measurement of the burden, resources use and health costs associated with herpes zoster and post-herpetic neuralgia in Mexico. Master study. Value Health. 2015;18(7):A870. doi:10.1016/j.jval.2015.09.009.
   Web of Science ®Google Scholar
• Acosta A, Rueda M, Castañeda-Cardona C, Gil-Rojas Y, Rosselli D. Cost-effectiveness of Lidocaine medicated patch compared with pregabalin and gabapentin for the treatment of postherpetic neuralgia and diabetic polyneuropathy in Colombia. Value Health. 2017;20(9):A867–8. doi:10.1016/j.jval.2017.08.2531.
   Web of Science ®Google Scholar
• Piedade A, Kashiura D, Engel T, Rodrigues C. Cost-effectiveness analysis of 5% Lidocaine medicated plaster monotherapy versus pregabalin or gabapentin in the treatment of post herpetic neuralgia and diabetic polyneuropathy under the perspective of Brazilian public healthcare system. Value Health. 2017;20:A221.
   Web of Science ®Google Scholar
• González KG, Alonzo-Romero PL, Campos AG. Herpes zoster oftálmico. Evaluación de complicaciones y secuelas oculares y su relación con diversos tratamientos. Dermatol Rev Mex. 2013;56:392–98.
   Google Scholar
• Kawai K, Rampakakis E, Tsai TF, Cheong HJ, Dhitavat J, Covarrubias AO, Yang L, Cashat-Cruz M, Monsanto H, Johnson K, et al. Predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from North and Latin America and Asia. Int J Infect Dis. 2015;34:126–31.
   PubMed Web of Science ®Google Scholar
• Vázquez M, Cravioto P, Galván F, Guarneros D, Pastor VH. Varicella and herpes zoster: challenges for public health. Salud Publica Mex. 2017;59:650–56.
   PubMed Web of Science ®Google Scholar
• Mendoza R, Francisca I, Talavera B, Claudia J. Comportamiento clínico y terapeutico del herpes zoster en el centro nacional de dermatología Doctor Francisco José Gómez Urcuyo enero 2002 - Diciembre 2006. 2007 [accessed 2022 Jul 27]. https://pesquisa.bvsalud.org/portal/resource/en/lil-592990.
   Google Scholar
• Sispro. Misiterio de Salud Colombia. 2020 [accessed 2021 Mar 12]. https://www.sispro.gov.co/Pages/Home.aspx.
   Google Scholar
• DGIS. Egresos Hospitalarios, Urgencias y Defunciones. Cubos dinámicos. Secretaría de Salud DGIS Mexico. 2020 [accessed 2020 Jul 16]. http://www.dgis.salud.gob.mx/contenidos/basesdedatos/bdc_egresoshosp_gobmx.html.
   Google Scholar
• Datasus. Informações de Saúde (TABNET). 2020 [accessed 2020 Jul 16]. http://www2.datasus.gov.br/DATASUS/index.php?area=02.
   Google Scholar
• Ministério da Saúde. Secretaria de Atenção Primária à Saúde (SAPS). 2021 [accessed 2021 Jul 1]. https://egestorab.saude.gov.br/paginas/acessoPublico/relatorios/relHistoricoCoberturaAB.xhtml.
   Google Scholar
• Departamento de Estadísticas e Información de Salud. Ministerio de Salud. Gobierno de Chile. 2020 [accessed 2020 July 16].
   Google Scholar
• XE. US Dollar to Brazilian real exchange rate chart. [accessed 2021 Jul 1]. https://www.xe.com/currencycharts/?from=USD&to=BRL&view=10Y.
   Google Scholar